Rapid impact of beta-amyloid on paxillin in a neural cell line - PubMed (original) (raw)

Rapid impact of beta-amyloid on paxillin in a neural cell line

M M Berg et al. J Neurosci Res. 1997.

Abstract

Beta-amyloid1-42 (Abeta) is a naturally occuring peptide whose accumulation in the brain is putatively coupled to Alzheimer's disease pathogenesis. Deleterious effects of Abeta on neurons have been linked to the inappropriate activation of signaling pathways within the cell (reviewed in Yankner, 1996), including tyrosine phosphorylation of focal adhesion kinase (FAK) (Zhang et al., 1994, 1996a,b). Here we have investigated the effects of Abeta on paxillin in a neural cell line. Paxillin, a substrate for FAK, is thought to act as a signal "integrator," functioning to link other proteins into multi-molecular signaling complexes (reviewed in Turner, 1994). Treatment of the rat central nervous system B103 cell line with aggregates of Abeta was found to induce the tyrosine phosphorylation of paxillin within 30 min, nearly 24 hr prior to significant cell death. Particularly striking was a subsequent "mobilization" of paxillin to the cytoskeleton in Abeta-treated cells. The amount of paxillin associated with the cytoskeleton in Abeta-treated cells was increased 10-fold over controls. The Abeta-induced paxillin accumulation could be visualized immunocytochemically, with an increase in number and size of paxillin-labeled focal contacts upon treatment with Abeta. This effect was specific, in that vinculin, another focal contact protein, was unaffected by Abeta. Disruption of f-actin, which inhibits both Abeta-induced neurotoxicity (Furukawa and Mattson, 1995) and focal contact signaling in B103 cells (Zhang et al., 1996b) was found to block the cytoskeletal paxillin accumulation. The rapid tyrosine phosphorylation and cytoskeletal mobilization of paxillin links Abeta to the activation of focal contact signaling events that may influence neuronal cytoskeletal architecture, gene expression, synaptic plasticity and cell viability.

PubMed Disclaimer

Cited by

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. Lambert MP, et al. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53. doi: 10.1073/pnas.95.11.6448. Proc Natl Acad Sci U S A. 1998. PMID: 9600986 Free PMC article.
Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampi.
Caltagarone J, Hamilton RL, Murdoch G, Jing Z, DeFranco DB, Bowser R. Caltagarone J, et al. J Neuropathol Exp Neurol. 2010 Apr;69(4):356-71. doi: 10.1097/NEN.0b013e3181d53d98. J Neuropathol Exp Neurol. 2010. PMID: 20448481 Free PMC article.
Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: relevance for immunotherapy.
Perez-Garmendia R, Ibarra-Bracamontes V, Vasilevko V, Luna-Muñoz J, Mena R, Govezensky T, Acero G, Manoutcharian K, Cribbs DH, Gevorkian G. Perez-Garmendia R, et al. J Neuroimmunol. 2010 Dec 15;229(1-2):248-55. doi: 10.1016/j.jneuroim.2010.08.020. Epub 2010 Sep 22. J Neuroimmunol. 2010. PMID: 20864186 Free PMC article.
A Soft Mechanical Phenotype of SH-SY5Y Neuroblastoma and Primary Human Neurons Is Resilient to Oligomeric Aβ(1-42) Injury.
Kruger TM, Bell KJ, Lansakara TI, Tivanski AV, Doorn JA, Stevens LL. Kruger TM, et al. ACS Chem Neurosci. 2020 Mar 18;11(6):840-850. doi: 10.1021/acschemneuro.9b00401. Epub 2020 Feb 28. ACS Chem Neurosci. 2020. PMID: 32058688 Free PMC article.
Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.
Grace EA, Busciglio J. Grace EA, et al. J Neurosci. 2003 Jan 15;23(2):493-502. doi: 10.1523/JNEUROSCI.23-02-00493.2003. J Neurosci. 2003. PMID: 12533609 Free PMC article.

Rapid impact of beta-amyloid on paxillin in a neural cell line - PubMed (original) (raw)